vTv Therapeutics Inc - Class A (VTVT)

NASDAQ

$32.38

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet unmet medical needs.

Website: https://vtvtherapeutics.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $54.33 (+67.79%)

Market Cap

$305M

Free Cash Flow Yield

-6.82%

Beta (5Y)

1.09

Price Chart

Adjust inflation

Log

Valuation

Market Cap$305M

P/S17944.71

P/B4.32

Profitability

Total Revenue (TTM)$17K

Gross Profit (TTM)$13M

EBITDA-$30M

Operating Margin-175382%

EPS-$4.12

Financial Health

Debt-to-Equity0.5%

Free Cash Flow Yield-6.82%

Growth & Risk

Revenue 5Y CAGR-5.03%

Beta (5Y)1.09

Sharpe Ratio1.25